Correlation Between News Corp and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both News Corp and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining News Corp and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between News Corp Cl and Viridian Therapeutics, you can compare the effects of market volatilities on News Corp and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in News Corp with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of News Corp and Viridian Therapeutics.
Diversification Opportunities for News Corp and Viridian Therapeutics
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between News and Viridian is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding News Corp Cl and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and News Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on News Corp Cl are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of News Corp i.e., News Corp and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between News Corp and Viridian Therapeutics
Assuming the 90 days trading horizon News Corp Cl is expected to generate 0.35 times more return on investment than Viridian Therapeutics. However, News Corp Cl is 2.86 times less risky than Viridian Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 2,742 in News Corp Cl on September 3, 2024 and sell it today you would earn a total of 172.00 from holding News Corp Cl or generate 6.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
News Corp Cl vs. Viridian Therapeutics
Performance |
| Timeline |
| News Corp Cl |
| Viridian Therapeutics |
News Corp and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with News Corp and Viridian Therapeutics
The main advantage of trading using opposite News Corp and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if News Corp position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| News Corp vs. Sunny Optical Technology | News Corp vs. Vitec Software Group | News Corp vs. Take Two Interactive Software | News Corp vs. Zurich Insurance Group |
| Viridian Therapeutics vs. MediaZest plc | Viridian Therapeutics vs. Catalyst Media Group | Viridian Therapeutics vs. Centaur Media | Viridian Therapeutics vs. XLMedia PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets |